Madrigal Pharmaceuticals (MDGL) Interest Coverage Ratio (2022 - 2025)
Madrigal Pharmaceuticals (MDGL) has disclosed Interest Coverage Ratio for 4 consecutive years, with 7.18 as the latest value for Q4 2025.
- On a quarterly basis, Interest Coverage Ratio rose 62.48% to 7.18 in Q4 2025 year-over-year; TTM through Dec 2025 was 13.45, a 60.36% increase, with the full-year FY2025 number at 13.45, up 60.36% from a year prior.
- Interest Coverage Ratio was 7.18 for Q4 2025 at Madrigal Pharmaceuticals, up from 15.3 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 7.18 in Q4 2025 to a low of 90.09 in Q2 2022.
- A 4-year average of 34.08 and a median of 29.8 in 2023 define the central range for Interest Coverage Ratio.
- Peak YoY movement for Interest Coverage Ratio: plummeted 49.19% in 2024, then skyrocketed 67.47% in 2025.
- Madrigal Pharmaceuticals' Interest Coverage Ratio stood at 50.71 in 2022, then soared by 41.81% to 29.51 in 2023, then soared by 35.11% to 19.15 in 2024, then soared by 62.48% to 7.18 in 2025.
- Per Business Quant, the three most recent readings for MDGL's Interest Coverage Ratio are 7.18 (Q4 2025), 15.3 (Q3 2025), and 14.46 (Q2 2025).